Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Bullinger

Showing results (181-190 of 385) with videos related to

Pageof 39
Sort By:
Plos One|August 19, 2021
COVID19-associated cardiomyocyte dysfunction, arrhythmias and the effect of CanakinumabSanzio Dimai, Lukas Semmler, Ashok Prabhu, et al.
Nature Cell Biology|December 25, 2012
SCFFbxo9 and CK2 direct the cellular response to growth factor withdrawal via Tel2/Tti1 degradation and promote survival in multiple myelomaVanesa Fernández-Sáiz, Bianca-Sabrina Targosz, Simone Lemeer, et al.
Cancer Management and Research|April 3, 2023
Sarcoma Patients Admitted to the Intensive Care Unit (ICU): Predictive Relevance of Common Sepsis and Performance ParametersJana K Striefler, Phung T Binder, Franziska Brandes, et al.
Leukemia|December 19, 2025
Dynamics of clonal hematopoiesis and cellular responses to stress-induced toxicity in autologous stem cell transplantationCatarina M Stein, Raphael Hablesreiter, Friederike Christen, et al.
The Journal of Clinical Investigation|December 4, 2012
CDX2-driven leukemogenesis involves KLF4 repression and deregulated PPARγ signalingKatrin Faber, Lars Bullinger, Christine Ragu, et al.
Sarcoma|February 27, 2019
Analysis of the CDK4/6 Cell Cycle Pathway in Leiomyosarcomas as a Potential Target for Inhibition by PalbociclibMichael J Böhm, Ralf Marienfeld, Daniela Jäger, et al.
Blood|March 1, 2019
NCAM1 (CD56) promotes leukemogenesis and confers drug resistance in AMLDaniel Sasca, Jakub Szybinski, Andrea Schüler, et al.
Cancer Cell|July 12, 2011
MLL-rearranged leukemia is dependent on aberrant H3K79 methylation by DOT1LKathrin M Bernt, Nan Zhu, Amit U Sinha, et al.
Nature Genetics|January 17, 2017
Precision oncology for acute myeloid leukemia using a knowledge bank approachMoritz Gerstung, Elli Papaemmanuil, Inigo Martincorena, et al.
Blood|July 19, 2011
Differential niche and Wnt requirements during acute myeloid leukemia progressionSteven W Lane, Yingzi J Wang, Cristina Lo Celso, et al.
Pageof 39

Showing results (181-190 of 385) with videos related to

Sort By:
Pageof 39
Plos One|August 19, 2021
COVID19-associated cardiomyocyte dysfunction, arrhythmias and the effect of CanakinumabSanzio Dimai, Lukas Semmler, Ashok Prabhu, et al.
Nature Cell Biology|December 25, 2012
SCFFbxo9 and CK2 direct the cellular response to growth factor withdrawal via Tel2/Tti1 degradation and promote survival in multiple myelomaVanesa Fernández-Sáiz, Bianca-Sabrina Targosz, Simone Lemeer, et al.
Cancer Management and Research|April 3, 2023
Sarcoma Patients Admitted to the Intensive Care Unit (ICU): Predictive Relevance of Common Sepsis and Performance ParametersJana K Striefler, Phung T Binder, Franziska Brandes, et al.
Leukemia|December 19, 2025
Dynamics of clonal hematopoiesis and cellular responses to stress-induced toxicity in autologous stem cell transplantationCatarina M Stein, Raphael Hablesreiter, Friederike Christen, et al.
The Journal of Clinical Investigation|December 4, 2012
CDX2-driven leukemogenesis involves KLF4 repression and deregulated PPARγ signalingKatrin Faber, Lars Bullinger, Christine Ragu, et al.
Sarcoma|February 27, 2019
Analysis of the CDK4/6 Cell Cycle Pathway in Leiomyosarcomas as a Potential Target for Inhibition by PalbociclibMichael J Böhm, Ralf Marienfeld, Daniela Jäger, et al.
Blood|March 1, 2019
NCAM1 (CD56) promotes leukemogenesis and confers drug resistance in AMLDaniel Sasca, Jakub Szybinski, Andrea Schüler, et al.
Cancer Cell|July 12, 2011
MLL-rearranged leukemia is dependent on aberrant H3K79 methylation by DOT1LKathrin M Bernt, Nan Zhu, Amit U Sinha, et al.
Nature Genetics|January 17, 2017
Precision oncology for acute myeloid leukemia using a knowledge bank approachMoritz Gerstung, Elli Papaemmanuil, Inigo Martincorena, et al.
Blood|July 19, 2011
Differential niche and Wnt requirements during acute myeloid leukemia progressionSteven W Lane, Yingzi J Wang, Cristina Lo Celso, et al.
Pageof 39